During her fight with Non, Hank is abducted by Non. At . headquarters, Kara asks Astra where Non took Hank, but she refuses to reveal anything. Kara tells James and Winn of Cat suspecting her to be Supergirl, a suspicion Cat continues to test through various challenges. Kara is present when Non contacts the ., offering to trade Hank for Astra. Much to her horror, Kara later has to sit by while General Lane tortures Astra with a Kryptonite injection. Kara later has to save Alex and another . agent from an explosion after Astra's revelation of Hank's location turns out to be a trap. At CatCo, Kara is given the dilemma of proving that she isn't Supergirl, or Cat will fire her. Later, Kara thanks Cat for the opportunity to work with her and resigns, explaining that Cat's suspicions make it impossible for her to do her job. Afterwards, she discovers James' injuries that he had sustained, after investigating Maxwell Lord, announcing that she'd go after him. While visiting Astra, Astra tells her that going through with the exchange is the only way to rescue Hank. Kara agrees, though there is initial protest from General Lane. She is present when the trade is made, and though Non springs an ambush, Astra calls off the attack, demanding that Non honor the agreement. Hank later uses his shapeshifting ability to impersonate Supergirl so that Cat can see her and Kara at the same time, and Kara is offered her job back. Though Kara is offered full-time job at the . by Hank, she rejects it because her relationships at CatCo are what humanizes her. She later has an online chat with Superman, who offers her both support, and assistance if she ever needs it. 
In Australia and New Zealand, orlistat is currently [update] available over-the-counter in 120 mg size (84 capsules to the pack). Initially available only with a prescription, it was reclassified as a " Pharmacist Only Medicine " in October 2003. In 2007 the Committee decided to keep orlistat as a Schedule 3 drug , but withdrew its authorization of direct-to-consumer Xenical advertising, stating this "increased pressure on pharmacists to provide orlistat to consumers...this in turn had the potential to result in inappropriate patterns of use".  Xenical has recently [ when? ] began being advertised direct-to-customers again.